Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.792 USD | -0.11% | -40.08% | -28.84% |
05-15 | Top Midday Decliners | MT |
05-15 | Bolt Biotherapeutics Stops Development of Trastuzumab Imbotolimod, Cuts Workforce by 50% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.84% | 30.23M | |
+9.72% | 115B | |
+11.68% | 106B | |
-2.59% | 21.96B | |
-13.30% | 21.87B | |
-5.29% | 19.21B | |
-4.27% | 18.08B | |
-38.57% | 17.71B | |
+6.50% | 14.32B | |
+33.98% | 12.42B |
- Stock Market
- Equities
- BOLT Stock
- News Bolt Biotherapeutics, Inc.
- Bolt Biotherapeutics : Stifel Starts Bolt Biotherapeutics at Buy With $40 Price Target